27 May, 2020
New! Polyclonal Antibodies Specific to Canine CRP

In dogs, C-reactive protein (CRP) can be used as a marker of inflammation. Its concentration in blood increases rapidly in systemic inflammation and decreases quickly during recovery. It has been shown to increase in disorders such as bacterial infections, sepsis and pyometra, as well as in the case of post-surgical infections.

Read more
27 May, 2020
Winner of the 2020 IFCC Distinguished Award for Contributions to Cardiovascular Diagnostics

Prof. Fred S. Apple (Hennepin Healthcare/Hennepin County Medical Center, Laboratory Medicine and Pathology, and University of Minnesota School of Medicine, Minneapolis MN, US) is the winner of the 2020 IFCC Distinguished Award for Contributions to Cardiovascular Diagnostics, sponsored by HyTest. This award honors an individual who has undertaken remarkable scientific work with cardiac markers or immunodiagnostic applications to improve cardiac disease diagnosis.

Read more
27 May, 2020
Meet HyTest China Team at CACLP Expo

We will attend the 17th China Association of Clinical Laboratory Practice Expo held at Nanchang Greenland International Expo Center, on 21-23 August.

Read more
29 Apr, 2020
New Product! Recombinant Rabbit Cardiac Troponin I Antibodies Targeted to Epitope Region 24-40

The cardiac isoform of Troponin I (cTnI) is used as a gold standard as marker of acute myocardial infarction (AMI). The region 24-40 aar of cTnI is a perspective target for monoclonal antibodies (MAb), because it is less affected by the action of autoantibodies and is not hindered by the other components of troponin complex.

Read more
16 Apr, 2020
HyTest Live Webinar - COVID-19: Biomarkers to Distinguish Severity and Prognosis

By watching this webinar, you will learn about: 
- the use of nucleic acid testing and serological testing for diagnostics of COVID-19, as well as the benefits and limitations of these methods for COVID-19 diagnostics
- the effects of SARS-CoV-2 on the cardiovascular system
- the role of cardiac and inflammatory biomarkers in distinguishing the severity and prognosis of COVID-19

Read more
13 Mar, 2020
COVID-19 Related Markers and HyTest Operations

The World Health Organization (WHO) declared the Coronavirus outbreak a pandemic on Wednesday, March 11, and we are very closely following the changing situation on a daily basis. We would like to confirm to you that we are continuing to supply our products as normal.

Read more
26 Feb, 2020
New Video Published: NT-proBNP Assays and Standardization

Heart failure is a severe health problem that is characterized by an increasing prevalence and economic cost.

Read more
14 Feb, 2020
We are Sponsoring Cancer Challenge

How can we make cancer research, treatment and life with cancer better? Read more and join the contest

Read more
31 Jan, 2020
HyTest Supports Fight against COVID-19

HyTest Shanghai has decided to cancel the opening ceremony of the new premises scheduled for the end of February 2020 due to the epidemic situation in China

Read more
29 Jan, 2020
New Products! NGAL Antibodies and Antigen

NGAL (neutrophil gelatinase-associated lipocalin) is a small glycoprotein found in blood and urine. It is expressed by kidney tubular cells after kidney injury and it has been indicated as a promising biomarker of acute kidney injury. In addition, NGAL concentration is known to increase in severe infections.

We provide several mouse and rabbit derived monoclonal antibodies specific to human NGAL. In addition, we have developed a recombinant NGAL protein that can be used as a calibrator or standard in NGAL immunoassays.

Read more
26 Nov, 2019
New Product! GFAP Antibodies

Traumatic brain injuries (TBIs), including concussions, are one of the main public health concerns globally. TBI diagnosis is currently based on clinical assessment using scores such as Glasgow coma scale and computer tomography. However, scores can be compromised for various reasons and the computer tomography is less than perfect too as even in severe cases the findings can be normal.

Read more
31 Oct, 2019
New Team Member - North America Sales Manager Karen Smith

With effect from October 2019, Karen has been the North America Sales Manager of HyTest.

Read more
30 Oct, 2019
New Editorial and Podcast: Relationship Between Obesity and BNP/NT-proBNP Measurements

Our researchers wrote an editorial for a Clinical Chemistry article addressing an important but poorly studied interrelationship between obesity and natriuretic peptide measurements.

Read more
10 Oct, 2019
Meet HyTest Team at Medica 2019

We will be attending Medica 2019 in November.

Read more
25 Sep, 2019
New Team Member - CCO Juhana Rauramo

We are delighted to introduce our latest team member, CCO Juhana Rauramo.

Read more
29 Aug, 2019
New Article: Troponin Complexes in the Blood of AMI Patients

Using several immunodiagnostic techniques, our researchers investigated in what forms cTnI and cTnT (as components of the troponin complexes) are present in the blood of patients with acute myocardial infarction.

Read more
29 Aug, 2019
New Article: Neprilysin-Derived BNP Fragments and Possible Options for Targeted Therapy in Heart Failure

The article describes the development of a novel immunoassay for the quantification of BNP fragments cleaved by neprilysin.

Read more
03 Jul, 2019
NEW product! Beta-amyloid 1-42 antibodies

Alzheimer’s disease is a progressive neurodegenerative disease and the most common cause of dementia. We provide three in vitro produced monoclonal antibodies that are specific to human beta-amyloid 1-42.

Read more
02 Jul, 2019
Meet us at AACC 2019 in Anaheim and Register to Workshop
We will be attending the 2019 AACC Annual Meeting & Clinical Lab Expo. The exhibition will be on August  6 - 8 in Anaheim.
Read more

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!